Testing effectiveness (Phase 2)Ended earlyNCT04768504
What this trial is testing
Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study
Who this might be right for
Immune-Mediated Colitis
Khashayar Esfahani 2